Active Shortage

GLN-OLMESARTAN HCTZ

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-OLMESARTAN HCTZ in Canada?

Yes. GLN-OLMESARTAN HCTZ 20MG 12.5MG has an active shortage reported to Health Canada (last updated October 29, 2026).

Why is GLN-OLMESARTAN HCTZ not available?

The reason the manufacturer reported: Demand increase for the drug.

When will GLN-OLMESARTAN HCTZ be available again?

The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~15 days remaining (estimate)

Affected strength20MG 12.5MG

Report last updated2026-10-29

Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02475707

Strength

20MG 12.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-10-29

Active Shortage

Demand increase for the drug.

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495